MONTGOMERY, Ala. ( WSFA ) - Nearly every U.S. Senate Republican signed a letter last week that called on the U.S. Food and Drug Administration and the Department of Health and Human Services to add more restrictions to generic brand abortion drugs.

Both of Alabama’s Senators, Katie Britt (R-Alabama) and Tommy Tuberville (R-Alabama) where among those to add their signatures.

In the letter, the group made the following recommendations:

Suspend the approval of any new generic versions of mifepristone pending the outcome of the [Risk Evaluation and Mitigation Strategies] REMS safety review.

Commit to ensuring that all generic versions of mifepristone are included in the ongoing reevaluation of prior REMS approvals.

Reinstate the in-person dispensing requirement for mifepristone and

See Full Page